Clinical trial
Biomarkers and Antithrombotic Treatment in Cervical Artery Dissection…
NCT02046460 · Stefan Engelter, Other · Completed
Key facts
| NCT number | NCT02046460 |
|---|---|
| Title | Biomarkers and Antithrombotic Treatment in Cervical Artery Dissection - TREAT-CAD |
| Official title | Biomarkers and Antithrombotic Treatment in Cervical Artery Dissection - TREAT-CAD |
| Acronym | TREAT-CAD |
| Lead sponsor | Stefan Engelter, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cervical Artery Dissection |
| Intervention type | Drug |
| Interventions | Acetylsalicylic acid, Vitamin K antagonist |
| Enrollment | 194 |
| Start date | Sep 1, 2013 |
| Primary completion | Jun 1, 2019 |
| Completion | Jun 1, 2019 |
| First posted | Jan 27, 2014 |
| Last update posted | May 21, 2024 |
| Countries | Denmark, Germany, Switzerland |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: